Evidence map›Paper›PMID 33458518›Full record

ArticleACS omega2021

Characterization and Evaluation of the Pro-Coagulant and Immunomodulatory Activities of Polysaccharides from

Wanchen Zhai, Enwei Wei, Rui Li, Tianyi Ji, Yueyao Jiang, Xiaoxiao Wang, Yiying Liu, Zhiying Ding, Hongli Zhou

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Molecules (Basel, Switzerland) · 2026
    Review
  4. Comprehensive review ofRSC advances · 2025
    Review
  5. Recent advances inFrontiers in pharmacology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in cellular and infection microbiology · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wanchen ZhaiSchool of Pharmaceutical Sciences, Jilin University, Changchun 130012, PR China.
Enwei WeiBethune Institute of Epigenetic Medicine, The First Hospital, Jilin University, Changchun 130012, PR China.
Rui LiDepartment of Pharmacy, China-Japan Union Hospital of Jilin University, Changchun 130012, PR China.
Tianyi JiSchool of Pharmaceutical Sciences, Jilin University, Changchun 130012, PR China.
Yueyao JiangSchool of Pharmaceutical Sciences, Jilin University, Changchun 130012, PR China.
Xiaoxiao WangJilin Engineering Research Center for Agricultural Resources and Comprehensive Utilization, Jilin Institute of Chemical Technology, Jilin 132022, PR China.
Yiying LiuJilin Engineering Research Center for Agricultural Resources and Comprehensive Utilization, Jilin Institute of Chemical Technology, Jilin 132022, PR China.
Zhiying DingSchool of Pharmaceutical Sciences, Jilin University, Changchun 130012, PR China.
Hongli ZhouJilin Engineering Research Center for Agricultural Resources and Comprehensive Utilization, Jilin Institute of Chemical Technology, Jilin 132022, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33458518
PMCPMC7807737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.